K201841 is an FDA 510(k) clearance for the EyeBOX. This device is classified as a Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (Class II - Special Controls, product code QEA).
Submitted by Oculogica, Inc. (New York, US). The FDA issued a Cleared decision on September 6, 2020, 66 days after receiving the submission on July 2, 2020.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1455. A Traumatic Brain Injury Eye Movement Assessment Aid Is A Prescription Device That Uses A Patients Tracked Eye Movements To Provide An Interpretation Of The Functional Condition Of The Patients Brain. This Device Is An Assessment Aid That Is Not Intended For Standalone Detection Or Diagnostic Purposes..
| 510(k) Number | K201841 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | July 02, 2020 |
| Decision Date | September 06, 2020 |
| Days to Decision | 66 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | QEA - Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.1455 |
| Definition | A Traumatic Brain Injury Eye Movement Assessment Aid Is A Prescription Device That Uses A Patients Tracked Eye Movements To Provide An Interpretation Of The Functional Condition Of The Patients Brain. This Device Is An Assessment Aid That Is Not Intended For Standalone Detection Or Diagnostic Purposes. |